Lisa Heß
| Name | Lisa Heß, née Lehmann |
| Education/Training | Molecular and Technical Medicine (B.Sc.) and Medical Diagnostic Technologies (M.Sc.) |
| Start of PhD Thesis and Group | 2018, Prof. Thomas Reinheckel |
| Subject of Thesis | Stage-dependent functions of dipeptidyl peptidase 9 in mammary cancer progression and neuronal differentiation |
| Research Interests | Tumor initiation, progression, metastases and brain development/neurodegenerative disorders |
| Methods and Techniques | Preclinical Models, Cell Culture Models of Neuronal Differentiation and 3D-Tumor Growth, Protease Activity Assays, Visualization and Analysis of Lysosomal Compartment, Protein Turnover/Degradation, and Expression Analysis |
| Publications | Schmidt J., Schmidt T., Golla M., Lehmann L., Weber J. J., Hübener-Schmid J., & Riess O. (2016). In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3. Journal of Neurochemistry, 150–162. https://doi.org/10.1111/jnc.13606 Capponi S., Stöffler N., Irimia M., Schaik F. M. A. Van, Ondik M. M., Biniossek M. L., Lehmann L., Mitschke J., Vermut M. W., Creyghton M. P., Graybiel A. M., Reinheckel T., Schilling O., Blencowe B. J., Crittenden J. R. and Timmers H. Th. M. (2019) Neuronal-specific microexon splicing of TAF1 mRNA is directly regulated by SRRM4 / nSR100. RNA Biol. 00, 1–13. |
| Contact | lias.lehmann[at]mol-med.uni-freiburg.de |